Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management (ROADMAP)
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients
Sponsor: Abbott Medical Devices
A observational or N/A phase clinical study on Heart Failure, this trial is completed. The trial is conducted by Abbott Medical Devices and has accumulated 9 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jul 2022 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Jul 2022 [monthly]
Completed
▶ Show 4 earlier versions
-
Feb 2019 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Feb 2019 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Oct 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- Thoratec Corporation
For direct contact, visit the study record on ClinicalTrials.gov .